MedTrace Logo

Antenatal Breastmilk Expression From Week 34 of Gestation

NCT05516199 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-01-16

No results posted yet for this study

Summary

In this pilot study, the investigators aim to examine if antenatal breastmilk expression from week 34 of pregnancy is a safe and feasible procedure for the mother and fetus. Furthermore, the investigators want to evaluate breastfeeding rates.

Conditions

  • Breastmilk Expression
  • Collection, Breastmilk
  • Breastfeeding
  • Healthy

Interventions

BEHAVIORAL

Antenatal breastmilk expression

Stimulation of the breast by hand/handexpression of breastmilk during pregnancy from week 34

BEHAVIORAL

Breastfeeding consultation

60 min standardized breastfeeding consultation with a trained midwife, with focus on practical breastfeeding skills

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Marie B Simonsen, M.D · OUH & SDU

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2023-09-30
Completion
2023-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05516199 on ClinicalTrials.gov